2 completed, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
Follow Behcet Disease: new trials by email Literature Review of Behcet Disease trials Research Report on Behcet Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease Placebo plus immunosuppression, Rivaroxaban plus immunosupression - Behcet Disease, Behcet Disease and Vascular Involvement | Phase 3 | Not yet recruiting | Marmara University | 110 | 2025-04-30 | 2025-04-13 |
| A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Infliximab - Behcet Disease | Phase 3 | Completed | Janssen Korea, Ltd., Korea | 33 | 2015-07-22 | 2019-10-17 |
| Phase III Study in Refractory Behcet's Disease AIN457, Placebo - Behcet Disease | Phase 3 | Completed | Novartis Pharmaceuticals | 118 | 2009-10-01 | 2015-08-31 |
Behcet Syndrome (3) · Panuveitis (1) · Postthrombotic Syndrome (1) · Uveitis (1) · Uveitis, Intermediate (1) · Uveitis, Posterior (1) · Venous Thrombosis (1)
Cardiovascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Eye Diseases (3) · Genetic Diseases, Inborn (3) · Hereditary Autoinflammatory Diseases (3) · Mouth Diseases (3) · Skin Diseases (3) · Skin Diseases, Genetic (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Stomatognathic Diseases (3) · Uveal Diseases (3) · Uveitis, Anterior (3) · Vascular Diseases (3) · Vasculitis (3)
Immune Tolerance (1) · Immunosuppression Therapy (1) · Infliximab (1) · Rivaroxaban (1) · secukinumab (1)
Janssen Korea, Ltd., Korea (1) · Marmara University (1) · Novartis Pharmaceuticals (1)
South Korea (2) · Turkey (Türkiye) (2) · Egypt (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · India (1) · Israel (1) · Italy (1) · Jordan (1) · Singapore (1) · Spain (1) · Switzerland (1) · Taiwan (1)
2009 (1)